Literature DB >> 8294566

Development of a competitive double antibody radioimmunoassay for rat metallothionein.

T Gasull1, D V Rebollo, B Romero, J Hidalgo.   

Abstract

A competitive double antibody radioimmunoassay (RIA) for rat metallothionein (MT) has been developed that has a detection limit of 100 pg and a range of 100 to 100000 pg. The antibody was raised in rabbits against rat MT-2 but it crossreacts equally with MT-1 and MT-2. However, when the assay is done in the presence of 2-mercaptoethanol the antibody is more specific for MT-2. Zn- and Cd- saturated MTs have similar responses in the assay. Addition of Cu(II) to Zn-MT (more than 6 mol Cu/mol MT) in non-reducing conditions modifies the response of the antibody, probably because of Cu(II) oxidation and later MT polymerization. Standard curves developed in the presence of cytosols from brain cortex, hypothalamus or liver did not differ from the standard curve, indicating the absence of interfering substances in the assay. Furthermore, serial dilutions of those cytosols paralleled the response of the standard curve, indicating that the response of the antibody was specific. For comparison, MT levels in some brain areas measured with the present RIA were compared with those measured with an established RIA. In addition, the expected effect of dexamethasone and stress on liver MT levels was clearly identified by this RIA. The results suggest that the present RIA can be used for quantitation of metallothionein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8294566     DOI: 10.1080/15321819308019851

Source DB:  PubMed          Journal:  J Immunoassay        ISSN: 0197-1522


  6 in total

1.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury.

Authors:  Roger S Chung; Milena Penkowa; Justin Dittmann; Carolyn E King; Carole Bartlett; Johanne W Asmussen; Juan Hidalgo; Javier Carrasco; Yee Kee J Leung; Adam K Walker; Samantha J Fung; Sarah A Dunlop; Melinda Fitzgerald; Lyn D Beazley; Meng I Chuah; James C Vickers; Adrian K West
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

3.  Evidence for a high molecular weight cytosolic factor that binds brain and liver metallothionein.

Authors:  T Gasull; J Hidalgo
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

4.  Cysteine-independent polymerization of metallothioneins in solutions and in crystals.

Authors:  T Hou; Y An; B Ru; R Bi; X Xu
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

5.  Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells.

Authors:  Fimmie Reinecke; Oksana Levanets; Yolanda Olivier; Roan Louw; Boitumelo Semete; Anne Grobler; Juan Hidalgo; Jan Smeitink; Antonel Olckers; Francois H Van der Westhuizen
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

6.  The renal metallothionein expression profile is altered in human lupus nephritis.

Authors:  Mikkel Faurschou; Milena Penkowa; Claus Bøgelund Andersen; Henrik Starklint; Søren Jacobsen
Journal:  Arthritis Res Ther       Date:  2008-07-06       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.